DWA
ATRS

Douglass Winthrop Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

Douglass Winthrop Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,000
Closed -$41K – 272
2022
Q1 		$41K Buy
+10,000
New +$36.3K ﹤0.01% 266

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Douglass Winthrop Advisors's ATRS Position: Q2 2022 in Review

Douglass Winthrop Advisors sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 10,000 shares — an estimated $41K sold.

Douglass Winthrop Advisors first reported a position in ATRS in Q1 2022 and held it in 1 quarter. The position peaked at $41K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Douglass Winthrop Advisors reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Douglass Winthrop Advisors sold 10,000 Antares Pharma, Inc. shares in Q2 2022, an estimated $41K.
  • Douglass Winthrop Advisors first reported a position in Antares Pharma, Inc. in Q1 2022 and held it in 1 quarter.
  • Douglass Winthrop Advisors's Antares Pharma, Inc. position peaked at $41K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Douglass Winthrop Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.